Ashouri E - Search Results

1

Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.

Ashouri E, Rajalingam K, Barani S, Farjadian S, Ghaderi A, Rajalingam R. Ashouri E, et al. Sci Rep. 2021 Apr 12;11(1):7932. doi: 10.1038/s41598-021-86964-y. Sci Rep. 2021. PMID: 33846431 Free PMC article.

2

Gene-specific PCR typing of killer cell immunoglobulin-like receptors.

Rajalingam R, Ashouri E. Rajalingam R, et al. Among authors: ashouri e. Methods Mol Biol. 2013;1034:239-55. doi: 10.1007/978-1-62703-493-7_12. Methods Mol Biol. 2013. PMID: 23775740 Free article.

3

KIR-HLA gene diversities and susceptibility to lung cancer.

Hematian Larki M, Ashouri E, Barani S, Ghayumi SMA, Ghaderi A, Rajalingam R. Hematian Larki M, et al. Among authors: ashouri e. Sci Rep. 2022 Oct 14;12(1):17237. doi: 10.1038/s41598-022-21062-1. Sci Rep. 2022. PMID: 36241658 Free PMC article.

4

KIR gene content diversity in four Iranian populations.

Ashouri E, Farjadian S, Reed EF, Ghaderi A, Rajalingam R. Ashouri E, et al. Immunogenetics. 2009 Jul;61(7):483-92. doi: 10.1007/s00251-009-0378-7. Epub 2009 Jun 12. Immunogenetics. 2009. PMID: 19521696 Free PMC article.

5

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

Levinson RD, Martin TM, Luo L, Ashouri E, Rosenbaum JT, Smith JR, Austin CR, Lutt JR, Rajalingam R. Levinson RD, et al. Among authors: ashouri e. Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1505-10. doi: 10.1167/iovs.09-4232. Epub 2009 Oct 22. Invest Ophthalmol Vis Sci. 2010. PMID: 19850842 Free PMC article.

6

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

Levinson RD, Okada AA, Ashouri E, Keino H, Rajalingam R. Levinson RD, et al. Among authors: ashouri e. Hum Immunol. 2010 Feb;71(2):192-4. doi: 10.1016/j.humimm.2009.11.001. Epub 2009 Nov 6. Hum Immunol. 2010. PMID: 19897003

7

Activating KIR2DS5 receptor is a risk for thyroid cancer.

Ashouri E, Dabbaghmanesh MH, Rowhanirad S, Bakhshayeshkaram M, Ranjbar Omrani G, Ghaderi A. Ashouri E, et al. Hum Immunol. 2012 Oct;73(10):1017-22. doi: 10.1016/j.humimm.2012.07.325. Epub 2012 Jul 23. Hum Immunol. 2012. PMID: 22836040

8

KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.

Levinson RD, Yung M, Meguro A, Ashouri E, Yu F, Mizuki N, Ohno S, Rajalingam R. Levinson RD, et al. Among authors: ashouri e. PLoS One. 2016 Aug 4;11(8):e0160392. doi: 10.1371/journal.pone.0160392. eCollection 2016. PLoS One. 2016. PMID: 27490240 Free PMC article.

9

KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians.

Barani S, Khademi B, Ashouri E, Ghaderi A. Barani S, et al. Among authors: ashouri e. Hum Immunol. 2018 Apr;79(4):218-223. doi: 10.1016/j.humimm.2018.01.012. Epub 2018 Feb 9. Hum Immunol. 2018. PMID: 29408295

10

KIR Variation in Iranians Combines High Haplotype and Allotype Diversity With an Abundance of Functional Inhibitory Receptors.

Alicata C, Ashouri E, Nemat-Gorgani N, Guethlein LA, Marin WM, Tao S, Moretta L, Hollenbach JA, Trowsdale J, Traherne JA, Ghaderi A, Parham P, Norman PJ. Alicata C, et al. Among authors: ashouri e. Front Immunol. 2020 Apr 2;11:556. doi: 10.3389/fimmu.2020.00556. eCollection 2020. Front Immunol. 2020. PMID: 32300348 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters